Fundraising Fox

Enrich Biosystems

Branford, US · Founded 2018 · Delaware corporation · 1 known investors

enrichbiosystems.com ↗

Enrich Biosystems develops TROVO, a benchtop instrument for high-throughput functional screening and live cell selection in cell engineering applications. The system enables parallel screening of thousands of cocultures in standard plates using 3D-printed hydrogel compartmentalization and light-based cell recovery for CAR-T and other cell therapy development.

BiotechDeep TechMedical Devicesin /enrich-biosystems-inc

Founders & leadership

QZ
Qi ZhaoExecutive Officer, Director
DW
Dong WangExecutive Officer, Director
CG
Cynthia GreenDirector
DW
Daniel WagnerDirector
CM
Christopher McLeodDirector
JT
Jay TeichDirector

Investors · 1

Connecticut InnovationsNew Haven · $500K – $2M

Reported raises · per SEC filings

Form D private placements
▶$1.4MraisedNov 2025 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel WagnerDirector
  • Qi ZhaoExecutive Officer, Director
  • Christopher McLeodDirector
  • Dong WangExecutive Officer, Director
  • Jay TeichDirector
Offering amount
$1.5M
Amount sold
$1.4M
First sale
Nov 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$750KraisedMay 2024 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cynthia GreenDirector
  • Qi ZhaoExecutive Officer, Director
  • Christopher McLeodDirector
  • Jay TeichDirector
  • Dong WangExecutive Officer, Director
Offering amount
$750K
Amount sold
$750K
First sale
May 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedMay 2024 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Qi ZhaoExecutive Officer, Director
  • Cynthia GreenDirector
  • Dong WangExecutive Officer, Director
  • Christopher McLeodDirector
  • Jay TeichDirector
Offering amount
$3.1M
Amount sold
$2.2M
First sale
May 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedJun 2022 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cynthia GreenDirector
  • Jay TeichDirector
  • Christopher McLeodDirector
  • Qi ZhaoExecutive Officer, Director
  • Dong WangExecutive Officer, Director
Offering amount
$4M
Amount sold
$3.8M
First sale
May 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news